News Daily News FDA Approves Sapien M3 for Transseptal Mitral Valve Replacement Michael O'Riordan December 23, 2025
News Conference News TCT 2025 AI-ECG Finds STEMI Faster, Cuts False-Positive Cath Lab Activations Todd Neale October 31, 2025
News Conference News TCT 2025 ENCIRCLE: Good Results With Sapien M3 Transseptal TMVR Todd Neale October 27, 2025
News Conference News TCT 2025 LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI L.A. McKeown October 27, 2025
News Features Imperfect Evidence: How Strong Is the Case for Transcatheter Tricuspid Valve Interventions? Todd Neale October 22, 2025
News Conference News NY Valves 2025 Promising Early Data With Navitor TAVI Valves Yael L. Maxwell July 02, 2025
News Daily News ‘Sobering’ Adverse Event Rate With Evoque Seen in Real-world Use Yael L. Maxwell June 18, 2025
News Daily News EuroPCR 2025 Underexpanded Acurate neo2 Valves Tied to Worse Outcomes: ACURATE IDE Michael O'Riordan May 28, 2025
News Conference News EuroPCR 2025 IVL Effective in Severely Calcified Lesions, Especially in Women Yael L. Maxwell May 22, 2025
News Daily News FDA Approves TAVI for Asymptomatic Patients With Severe Aortic Stenosis Michael O'Riordan May 01, 2025
News Conference News HRS 2025 Pairing CIED Lead Extraction With Tricuspid Interventions Appears Safe Todd Neale April 28, 2025
News Daily News PERFORMANCE II: Low Stroke Rate Seen With All-Inclusive Carotid Stent L.A. McKeown February 11, 2025
News Features Reimbursement Issues Seem to Be Holding Renal Denervation Back Todd Neale December 19, 2024
News Conference News VIVA 2024 Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK L.A. McKeown November 05, 2024
News Conference News TCT 2024 ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients Todd Neale October 30, 2024
News Conference News TCT 2024 ALIGN-AR at 2 Years Shows Promise for TAVI With Trilogy in Aortic Regurgitation Yael L. Maxwell October 29, 2024
News Conference News TCT 2024 TRILUMINATE: More Patient Data Reassure on TEER’s Benefits for Severe TR Michael O'Riordan October 29, 2024